CHRONIC ATRIAL FIBRILLATION News, Sports, Shopping, Travel information

Looking for Atrial Fibrillation?
Find Top Rated Atrial Fibrillation Listings! Save Time and Money. Check the site for Atrial Fibrillation
netshoppers.com

Warfarin Underused In Atrial Fibrillation Patients
tuesday, oct. 14 (healthday news) -- a new study reports that warfarin, a common treatment for atrial fibrillation, is either not prescribed by u.s. doctors as often as it could be or, when it is, not at optimal therapeutic doses.
news.yahoo.com

Warfarin Underused In Atrial Fibrillation Patients - Healthscout
tuesday, oct. 14 (healthday news) -- a new study reports that warfarin, a common treatment for atrial fibrillation, is either not prescribed by u.s. doctors as often as it could be or, when it is, not at optimal therapeutic doses. more than 2 million ...
www.healthscout.com

St. Jude Medical Announces European Ce Mark Approval Of Implantable ... - Genetic Engineering News
st. jude medical, inc. ( nyse:stj ) today announced it has received approval for european ce marking of its sjm confirm(tm) implantable cardiac monitor (icm), a compact device designed to detect atrial fibrillation (af) and other abnormal heart ...
www.genengnews.com

St. Jude Medical Announces European Ce Mark Approval Of Implantable Device For The Detection Of Atrial Fibrillation ...
st. jude medical, inc. (nyse:stj) today announced it has received approval for european ce marking of its sjm confirm(tm) implantable cardiac monitor (icm), a compact device designed to detect atrial fibrillation (af) and other abnormal heart rhythms.
www.centredaily.com

Warfarin Underused In Atrial Fibrillation Patients
study says blood thinner not prescribed often enough, but notes it's hard to manage.
www.healthcentral.com

St. Jude Medical Announces U.s. And European Approval Of Angio-seal ... - Pr Inside
www.sjm.com - st. jude medical angela craig, 651-481-7789 investor relations or kathleen janasz, 651-415-7042 media relations st. jude medical, inc. (nyse:stj) today announced u.s. food and drug administration (fda) and european ce mark approval of ...
www.pr-inside.com

Warfarin Warning: Shortfalls In Anticoagulation For Af Up Risks Of Ich ... - Medscape News
physicians - maximum of 0.25 ama pra category 1 credit(s) ™ for physicians; family physicians - up to 0.25 aafp prescribed credit(s) for physicians to participate in this internet activity: (1) review the target audience, learning objectives, and ...
www.medscape.com

St. Jude Medical Announces U.s. And European Approval Of Angio-seal Evolution Vascular Closure Device
st. jude medical, inc. (nyse:stj) today announced u.s. food and drug administration (fda) and european ce mark approval of the angio-seal(tm) evolution(tm) vascular closure device. the approval and global launch was announced at the transcatheter cardiovascular therapeutics conference in washington, d.c.
www.centredaily.com

Death Records For October 12, 2008
baumgart, mary delores; 84, evansville, died sept. 25, cardiopulmonary arrest, secondary to aspiration pneumonia. bolin, forrest e.; 85, francisco, ind., died sept. 23, respiratory failure, pneumonia.
www.courierpress.com

Thirty-seven Uninterrupted Years Of Hemodialysis: A Case Report - Medscape News
a patient is presented who was on uninterrupted hemodialysis for 37 years. she did extremely well for much of her time on hemodialysis. significant issues that occurred included multiple vascular access problems, cardiac arrhythmias, osteodystrophy ...
www.medscape.com

Top-rated Hospitals Continue To Deliver Better Care - Medicinenet.com
thursday, jan. 31 (healthday news) -- patients admitted to the top-rated hospitals in the united states have an average 27 percent lower risk of dying than patients admitted to other hospitals in the country, a new study shows. released thursday by ...
www.medicinenet.com

Xarelto(r) Approved In Canada - Venous Blood Clot Prevention After ... - Medical News Today
health canada has granted bayer healthcare marketing authorization for the anticoagulant xarelto® (rivaroxaban), taken as one tablet, once-daily, for the prevention of venous thromboembolic events (vte) in patients who have undergone elective total ...
www.medicalnewstoday.com

British Journal Of Cardiology - Medscape News
efficacy of ezetimibe and future role in managing high risk hyperlipidaemia... cost-consequences analysis of natriuretic peptide assays... cost-effectiveness and use of natriuretic peptides in clinical practice... angina ?- more of a chronic problem ...
www.medscape.com

Former U.s. Army Parachutist Becomes First Person Implanted With The ... - Medical News Today
st. jude medical, inc. (nyse:stj) announced the first patient implant of an eon mini™, the world's smallest, longest-lasting, rechargeable neurostimulator to treat chronic pain of the trunk or limbs and pain from failed back surgery. a 26-year-old ...
www.medicalnewstoday.com

Bayer’s Xarelto Approved In Canada - Phramalive.com
first approval for bayer’s new oral, once-daily anticoagulant / marketing to start immediately / first-in-class product to demonstrate superior efficacy to standard of care / most studied oral, direct factor xa inhibitor in the world today ...
www.pharmalive.com